泰格医药
Hangzhou, CN · 1 known investors
Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices. Founded in 2004 and publicly listed (300347.SZ / 3347.HK), it provides services including clinical monitoring, regulatory affairs, data management, and site management.
BiotechDigital HealthHealthtechMedical Devices
Investors · 1
Competitors · 5
by search overlapPower15 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Advarra15 shared keywordsAdvarra provides technology platforms and services for clinical trials, including IRB review/oversight, clinical trial management systems (CTMS), regulatory document management, and data capture tools. It serves research sites, institutions, sponsors, and CROs to improve trial operations, compliance, and collaboration across the clinical research ecosystem.
Iconplc14 shared keywordsICON is a clinical research organization that provides drug and medical device development services, including full-service outsourcing, early clinical and bioanalytical solutions, specialty laboratories, cardiac safety monitoring, market access consulting, and AI-enabled clinical trial platforms. It serves pharmaceutical companies, biotech firms, and other trial sponsors across the clinical trial lifecycle.
Novotech13 shared keywordsNovotech is a contract research organization (CRO) that provides clinical trial execution and scientific advisory services for biotech and biopharma sponsors, including complex cell and gene therapy trials. It has a strong regional focus on the Asia-Pacific market.
IQVIA13 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Companies competing with 泰格医药 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does 泰格医药 do?
- Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices. Founded in 2004 and publicly listed (300347.SZ / 3347.HK), it provides services including clinical monitoring, regulatory affairs, data management, and site management.
- Who are 泰格医药's investors?
- 泰格医药's investors include Highlight Capital.
- Where is 泰格医药 headquartered?
- 泰格医药 is headquartered in Hangzhou, CN.